Literature DB >> 15815883

Budd-Chiari syndrome associated with visceral leishmaniasis and factor V Leiden mutation.

Emel Gürkan1, Cağatay Unsal, Fikri Başlamişli, Didem Arslan.   

Abstract

We here report a case of subacute Budd-Chiari syndrome (BCS) related to Factor V Leiden (FVL) mutation in the presence of visceral leishmaniasis. A 17-year-old man was admitted to hospital because of abdominal pain, pretibial edema and fever. The clinical picture of BCS had been developed within several months. BCS was diagnosed by radiographic examination. On DNA analysis, a heterozygote Arg506Gln mutation in the factor V gene was found. Histological examination of the bone marrow showed intracellular leishmania amastigotes. Despite appropriate treatment patient's clinical condition deteriorated rapidly and died with multiorgan failure. FVL mutation is the most common procoagulant disorder and account for many cases of BCS. This case report demonstrates that in addition to duration and severity of the disease accompanying conditions including infections are prognostically significant for the outcome of this potentially lethal disease.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15815883     DOI: 10.1007/s11239-005-0347-4

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  21 in total

Review 1.  The Budd-Chiari syndrome.

Authors:  K V Narayanan Menon; Vijay Shah; Patrick S Kamath
Journal:  N Engl J Med       Date:  2004-02-05       Impact factor: 91.245

2.  Factor V Leiden related Budd-Chiari syndrome.

Authors:  P Deltenre; M H Denninger; S Hillaire; M C Guillin; N Casadevall; J Brière; S Erlinger; D C Valla
Journal:  Gut       Date:  2001-02       Impact factor: 23.059

3.  [Visceral leishmaniasis associated with disseminated intravascular coagulation. Report of 2 cases].

Authors:  F Gonzalvo; P Marco; S Soler; J Portilla
Journal:  Med Clin (Barc)       Date:  1993-03-27       Impact factor: 1.725

4.  [Visceral leishmaniasis associated with disseminated intravascular coagulation. Apropos of a case].

Authors:  L Mateos Polo; A Martínez Sapiña; J R Gil Llano; F Ruiz Llana
Journal:  An Med Interna       Date:  1994-10

Review 5.  Budd-Chiari syndrome: etiology, diagnosis and management.

Authors:  M C Mitchell; J K Boitnott; S Kaufman; J L Cameron; W C Maddrey
Journal:  Medicine (Baltimore)       Date:  1982-07       Impact factor: 1.889

6.  Kala-azar as a cause of disseminated intravascular coagulation.

Authors:  E R Blount; R Hartmann; J Nernoff
Journal:  Clin Pediatr (Phila)       Date:  1980-02       Impact factor: 1.168

7.  Prevalence of the factor V Leiden mutation in hepatic and portal vein thrombosis.

Authors:  A E Mahmoud; E Elias; N Beauchamp; J T Wilde
Journal:  Gut       Date:  1997-06       Impact factor: 23.059

8.  Factor V Leiden mutation, prothrombin gene mutation, and deficiencies in coagulation inhibitors associated with Budd-Chiari syndrome and portal vein thrombosis: results of a case-control study.

Authors:  H L Janssen; J R Meinardi; F P Vleggaar; S H van Uum; E B Haagsma; F J van Der Meer; J van Hattum; R A Chamuleau; R P Adang; J P Vandenbroucke; B van Hoek; F R Rosendaal
Journal:  Blood       Date:  2000-10-01       Impact factor: 22.113

9.  Acute Budd-Chiari syndrome with fulminant hepatic failure in a pregnant woman with factor V Leiden mutation.

Authors:  P Fickert; H Ramschak; L Kenner; G Hoefler; T A Hinterleitner; W Petritsch; M Klimpfinger; G J Krejs; R E Stauber
Journal:  Gastroenterology       Date:  1996-12       Impact factor: 22.682

10.  [Visceral leishmaniasis and multiple organ failure].

Authors:  A Mesejo; C Núñez; A Llombart; P L Pérez; M Simó; F Ruiz; J Blanquer
Journal:  Enferm Infecc Microbiol Clin       Date:  1993-12       Impact factor: 1.731

View more
  1 in total

1.  Visceral Leishmaniasis in a patient with rheumatoid arthritis undergoing treatment with methotrexate: Case report and review of the literature.

Authors:  Kyriakos Trigkidis; Eleni Geladari; Evangelos Kokkinakis; Natalia Vallianou
Journal:  Eur J Rheumatol       Date:  2017-04-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.